Targeted Therapy Treatment Innovations in AML - Episode 4

Part 2: IDH1 & IDH2 Inhibitors In Newly Diagnosed AML

Expert continues discussion of IDH1 and IDH2 inhibitors in AML and examines prioritization of IDH1 and IDH2 inhibitors versus venetoclax in newly diagnosed AML.